Serina Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	23	15	21	41	57	69	107
Market Cap Growth	-	-30.23%	-49.36%	-27.81%	-16.39%	-36.04%	-
Enterprise Value	27	19	38	54	63	68	100
PE Ratio	-0.99	-0.99	-2.00	-4.77	-5.27	-5.64	-14.28
PS Ratio	161.86	102.90	615.97	287.18	158.69	39.65	76.74
PB Ratio	4.20	2.67	-1.22	-3.49	-11.20	30.89	14.39
P/FCF Ratio	-1.87	-1.87	-3.53	-5.26	-7.31	-6.34	-13.36
P/OCF Ratio	-1.87	-1.87	-3.53	-5.26	-7.33	-6.74	-13.40
EV/Sales Ratio	189.81	130.85	1128.59	374.46	174.67	39.42	71.94
EV/EBITDA Ratio	-1.90	-1.90	-5.49	-7.24	-6.85	-6.15	-14.41
EV/EBIT Ratio	-1.88	-1.88	-5.38	-7.12	-6.03	-5.66	-13.39
EV/FCF Ratio	-2.38	-2.38	-6.46	-6.86	-8.05	-6.31	-12.53
Debt / Equity Ratio	0.80	0.80	-1.05	-1.12	-1.23	0.88	-
Debt / EBITDA Ratio	-0.45	-0.45	-2.59	-1.77	-0.68	-0.18	-
Debt / FCF Ratio	-0.56	-0.56	-3.05	-1.68	-0.80	-0.18	-
Quick Ratio	0.08	0.08	0.07	0.07	0.16	0.82	2.80
Current Ratio	0.13	0.13	0.24	0.25	0.43	1.23	3.22
Asset Turnover	0.01	0.01	0.01	0.05	0.08	0.18	0.14
Interest Coverage	-2.02	-2.02	-2.14	-6.91	-25.89	-	-
Return on Equity (ROE)	92.30%	92.30%	73.30%	96.20%	363.70%	-214.90%	-101.90%
Return on Assets (ROA)	-120.90%	-120.90%	-396.90%	-307.60%	-241.80%	-127.30%	-73.90%
Return on Capital (ROIC)	-100.43%	-100.43%	-763.38%	-546.35%	-847.03%	-300.89%	-151.00%
Earnings Yield	-64.41%	-101.31%	-49.95%	-20.98%	-18.97%	-17.74%	-7.00%
FCF Yield	-33.94%	-53.38%	-28.36%	-18.99%	-13.68%	-15.76%	-7.48%
Buyback Yield / Dilution	-	-0.16%	-0.58%	-1.07%	-6.75%	-13.93%
Total Shareholder Return	-	-0.16%	-0.58%	-1.07%	-6.75%	-13.93%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).